Gateway Pharmaceutical is a specialty drug-delivery company focusing on reformulation of traditional antibiotics for target delivery of drug to bacteria location.
Our Team has an average of more than
15 years of pharmaceutical industrial experience in formulation and process development, analytical testing, scale-up manufacturing, pharmacokinetic and clinical studies, and regulatory submission.
Innovating site-specific delivery of antibiotics to combat antibiotic resistance threats to the United States and the World.
BioSTL Award in 2018 Venture Showcase
August 2018 – Received NIH SBIR phase I grant award on the development of a new Colon-Targeting Metronidazole Treatment
for Clostridium difficile infection.
November 7, 2018 – Presented and won the BioSTL Award on the 10th Startup Connection Venture Showcase in St. Louis.
March 17, 2020 – US patent 10,588,864 entitled “Pharmaceutical Compositions for Colon-Specific Delivery”.